Drug Evaluations

A two-page summary on newly marketed drugs including the therapeutic classification, indications, pharmacology and pharmacokinetics, summary of clinical trials, reactions and interactions, dosing, comparative cost and place in therapy. This publication is issued up to 24 times per year.

Sample publication of a Drug Evaluation

Below are the titles of this publication issued in 2009.

Doripenem

December 2009

Methyl Aminolevulinate Hydrochloride (Aktinic keratoses & Basal Cell Carcinoma)

November 2009

Epelrenone

October 2009

Ethinyl estradiol/Drospirenone (Yaz®)

September 2009

Zoster Vaccine

August 2009

Loteprednol Etabonate 0.5%

July 2009

Loteprednol Etabonate 0.2%

June 2009

Desvenlafaxine Succinate

May 2009

Ciclesonide Nasal Spray

April 2009

Ustekinumab Injection

March 2009

Olmesartan Medoxomil & Olmesartan Medoxomil/Hydrochlorothiazide

February 2009

Insulin Glulisine

January 2009